310 related articles for article (PubMed ID: 9986790)
1. Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay.
Okuma K; Nakamura M; Nakano S; Niho Y; Matsuura Y
Virology; 1999 Feb; 254(2):235-44. PubMed ID: 9986790
[TBL] [Abstract][Full Text] [Related]
2. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
[TBL] [Abstract][Full Text] [Related]
3. Rapid syncytium formation between human T-cell leukaemia virus type-I (HTLV-I)-infected T-cells and human nervous system cells: a possible implication for tropical spastic paraparesis/HTLV-I associated myelopathy.
Mor-Vaknin N; Turgeman H; Torgeman A; Wolfson M; Huleihel M; Aboud M
Cell Biol Int; 1998; 22(2):95-103. PubMed ID: 9878096
[TBL] [Abstract][Full Text] [Related]
4. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
[TBL] [Abstract][Full Text] [Related]
5. Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus.
Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
Biochem Biophys Res Commun; 2001 Nov; 289(1):1-6. PubMed ID: 11708767
[TBL] [Abstract][Full Text] [Related]
6. Modification of a viral envelope glycoprotein cell-cell fusion assay by utilizing plasmid encoded bacteriophage RNA polymerase.
Lin G; Murphy SL; Gaulton GN; Hoxie JA
J Virol Methods; 2005 Sep; 128(1-2):135-42. PubMed ID: 15941597
[TBL] [Abstract][Full Text] [Related]
7. Chimeric synthetic peptides from the envelope (gp46) and the transmembrane (gp21) glycoproteins for the detection of antibodies to human T-cell leukemia virus type II.
Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
Biochem Biophys Res Commun; 2001 Nov; 289(1):7-12. PubMed ID: 11708768
[TBL] [Abstract][Full Text] [Related]
8. Heat shock cognate protein 70 is a cell fusion-enhancing factor but not an entry factor for human T-cell lymphotropic virus type I.
Fang D; Haraguchi Y; Jinno A; Soda Y; Shimizu N; Hoshino H
Biochem Biophys Res Commun; 1999 Aug; 261(2):357-63. PubMed ID: 10425190
[TBL] [Abstract][Full Text] [Related]
9. Enhanced human T-cell lymphotropic virus type I expression following induction of the cellular stress response.
Andrews JM; Oglesbee MJ; Trevino AV; Guyot DJ; Newbound GC; Lairmore MD
Virology; 1995 Apr; 208(2):816-20. PubMed ID: 7747457
[TBL] [Abstract][Full Text] [Related]
10. A new sensitive and quantitative HTLV-I-mediated cell fusion assay in T cells.
Paré ME; Gauthier S; Landry S; Sun J; Legault E; Leclerc D; Tanaka Y; Marriott SJ; Tremblay MJ; Barbeau B
Virology; 2005 Aug; 338(2):309-22. PubMed ID: 15963547
[TBL] [Abstract][Full Text] [Related]
11. [Expression of a fragment of the env gene, coding for the GP46 surface glycoprotein of the human T-cell leukemia virus, in Escherichia coli cells].
Bondarenko VO; Kazennova EV; Bobkova MR; Prilipov AG; Bobkov AF
Mol Gen Mikrobiol Virusol; 2000; (3):33-6. PubMed ID: 10975079
[TBL] [Abstract][Full Text] [Related]
12. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.
Kuroki M; Nakamura M; Itoyama Y; Tanaka Y; Shiraki H; Baba E; Esaki T; Tatsumoto T; Nagafuchi S; Nakano S
J Immunol; 1992 Aug; 149(3):940-8. PubMed ID: 1378869
[TBL] [Abstract][Full Text] [Related]
13. Human Dlg protein binds to the envelope glycoproteins of human T-cell leukemia virus type 1 and regulates envelope mediated cell-cell fusion in T lymphocytes.
Blot V; Delamarre L; Perugi F; Pham D; Bénichou S; Benarous R; Hanada T; Chishti AH; Dokhélar MC; Pique C
J Cell Sci; 2004 Aug; 117(Pt 17):3983-93. PubMed ID: 15286176
[TBL] [Abstract][Full Text] [Related]
14. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.
Tanaka Y; Zeng L; Shiraki H; Shida H; Tozawa H
J Immunol; 1991 Jul; 147(1):354-60. PubMed ID: 1711082
[TBL] [Abstract][Full Text] [Related]
15. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
[TBL] [Abstract][Full Text] [Related]
16. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to the envelope glycoprotein of human T cell leukemia virus type 1 robustly activate cell-mediated cytotoxic responses and directly neutralize viral infectivity at multiple steps of the entry process.
Kuo CW; Mirsaliotis A; Brighty DW
J Immunol; 2011 Jul; 187(1):361-71. PubMed ID: 21646298
[TBL] [Abstract][Full Text] [Related]
18. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.
Shuh M; Hill SA; Derse D
Virology; 1999 Sep; 262(2):442-51. PubMed ID: 10502522
[TBL] [Abstract][Full Text] [Related]
19. Rapid generation of antibodies against the HTLV-II external envelope protein by growth of mouse plasmacytomas in SCID mice.
Li QX; Camerini D; Kuritzkes DR; Chen IS
Virology; 1995 Dec; 214(2):680-4. PubMed ID: 8553576
[TBL] [Abstract][Full Text] [Related]
20. The conserved glycine-rich segment linking the N-terminal fusion peptide to the coiled coil of human T-cell leukemia virus type 1 transmembrane glycoprotein gp21 is a determinant of membrane fusion function.
Wilson KA; Bär S; Maerz AL; Alizon M; Poumbourios P
J Virol; 2005 Apr; 79(7):4533-9. PubMed ID: 15767455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
